Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 23
Filtrar
1.
Epileptic Disord ; 2024 May 23.
Artigo em Inglês | MEDLINE | ID: mdl-38780451

RESUMO

Pathogenic variants in CACNA1E are associated with early-onset epileptic and developmental encephalopathy (DEE). Severe to profound global developmental delay, early-onset refractory seizures, severe hypotonia, and macrocephaly are the main clinical features. Patients harboring the recurrent CACNA1E variant p.(Gly352Arg) typically present with the combination of early-onset DEE, dystonia/dyskinesia, and contractures. We describe a 2-year-and-11-month-old girl carrying the p.(Gly352Arg) CACNA1E variant. She has a severe DEE with very frequent drug-resistant seizures, profound hypotonia, and episodes of dystonia and dyskinesia. Long-term video-EEG-monitoring documented subsequent tonic asymmetric seizures during wakefulness and mild paroxysmal dyskinesias of the trunk out of sleep which were thought to be a movement disorder and instead turned out to be focal hyperkinetic seizures. This is the first documented description of the EEG findings in this disorder. Our report highlights a possible overlap between cortical and subcortical phenomena in CACNA1E-DEE. We also underline how a careful electro-clinical evaluation might be necessary for a correct discernment between the two disorders, playing a fundamental role in the clinical assessment and proper management of children with CACNA1E-DEE.

2.
Eur J Paediatr Neurol ; 42: 75-81, 2023 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-36584475

RESUMO

The aim was to determine school performance and psychiatric comorbidity in children with childhood absence epilepsy (CAE). We reviewed the medical records in children with ICD-10 codes for idiopathic generalized epilepsy before 18 years of age, and pediatric neurologists confirmed the International League Against Epilepsy criteria for CAE were met. Control groups were the general pediatric population or children with non-neurological chronic disease. Outcomes were from nationwide and population-based registers on school performance and psychiatric comorbidity. We compared the mean grade point average using linear regression and estimated hazard ratios (HR) using Cox regression for the other outcomes. Analyses were adjusted for the child's sex, and year of birth, and parental highest education, receipt of cash benefits or early disability pension. We included 114 children with CAE with a median age at onset of 5.9 years (interquartile range = 4.5-7.3 years). Compared with both population controls and non-neurological chronically ill children, children with CAE had increased hazard of special needs education (HR = 2.7, 95% confidence interval (CI) = 1.8-4.1, p < 0.0001), lower grade point average at 9th grade by 1.7 grade points (95% CI = -2.5 to -1.0, p < 0.001), increased ADHD medicine use (HR = 4.4, 95% CI = 2.7-7.2, p < 0.001), increased sleep medicine use (HR = 2.7, 95% CI = 1.7-4.3, p < 0.001), and increased psychiatry visits (HR = 2.1, 95% CI = 1.1-4.0, p = 0.03). In conclusion, children with CAE have increased psychiatric comorbidity and a considerable proportion of these children receive special needs education in primary/secondary school, albeit insufficient to normalize their considerably lower grade point average in the 9th grade.


Assuntos
Epilepsia Tipo Ausência , Epilepsia Generalizada , Criança , Humanos , Pré-Escolar , Estudos de Coortes , Epilepsia Tipo Ausência/epidemiologia , Comorbidade , Dinamarca/epidemiologia
3.
Cancers (Basel) ; 14(23)2022 Nov 28.
Artigo em Inglês | MEDLINE | ID: mdl-36497340

RESUMO

Liquid biopsy has improved significantly over the last decade and is attracting attention as a tool that can complement tissue biopsy to evaluate the genetic landscape of solid tumors. In the present study, we evaluated the usefulness of liquid biopsy in daily oncology practice in different clinical contexts. We studied ctDNA and tissue biopsy to investigate EGFR, KRAS, NRAS, and BRAF mutations from 199 cancer patients between January 2016 and March 2021. The study included 114 male and 85 female patients with a median age of 68 years. A total of 122 cases were lung carcinoma, 53 were colorectal carcinoma, and 24 were melanoma. Liquid biopsy was positive for a potentially druggable driver mutation in 14 lung and colorectal carcinoma where tissue biopsy was not performed, and in two (3%) lung carcinoma patients whose tissue biopsy was negative. Liquid biopsy identified nine (45%) de novo EGFR-T790M mutations during TKI-treatment follow-up in lung carcinoma. BRAF-V600 mutation resurgence was detected in three (12.5%) melanoma patients during follow-up. Our results confirm the value of liquid biopsy in routine clinical oncologic practice for targeted therapy, diagnosis of resistance to treatment, and cancer follow-up.

4.
J Clin Med ; 11(24)2022 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-36556046

RESUMO

Muscle-invasive urothelial carcinoma represents 20% of newly diagnosed cases of bladder cancer, and most cases show aggressive biological behavior with a poor prognosis. It is necessary to identify biomarkers that can be used as prognostic and predictive factors in daily clinical practice. In our study, we analyzed different antibodies in selected cases of muscle-invasive urinary bladder carcinoma and lymph node metastasis to identify immunohistochemical types and their value as possible prognostic factors. A total of 38 patients were included, 87% men and 13% women, with a mean age of 67.8 years. The most frequent histopathological type was urothelial carcinoma. In the primary lesion, the mixed type was the most common. In unilateral metastasis, the mixed type was the most frequently found. In cases of primary lesions and bilateral metastasis, the luminal and mixed types were observed. The luminal subtype was the most stable in immunohistochemical expression across primary tumors and metastases. The basal type showed a better prognosis in terms of disease-free survival. In conclusion, immunohistochemical studies are useful in assessing primary and metastatic lesions in patients with urothelial carcinoma. Immunohistochemical classification can typify muscle-invasive urothelial carcinoma, and the immunophenotype seems to have prognostic implications.

5.
J Clin Med ; 11(16)2022 Aug 14.
Artigo em Inglês | MEDLINE | ID: mdl-36012987

RESUMO

Circulating osteogenic precursor (COP) cells are peripheral blood cells with a capacity for osteogenesis. The objective of our study was to ascertain the percentage of COPs as an early biomarker of osteoporosis and the effect of these cells in response to Denosumab (DmAb) (anti-resorptive) or to Teriparatide (TPDP) (anabolic) as very effective drugs in the treatment of the illness. A first study was conducted on healthy volunteers, with three age ranges, to determine the percentage of COPs and relate it to their anthropometric and biochemical characteristics, followed by a second longitudinal study on patients with osteoporosis, whereby one group of patients was treated with TPTD and another with DmAb. All were analyzed by cytometry for COP percentage in blood, bone turnover markers, and bone mass. Our findings show that COPs are influenced by age and become more prolific in the stages of growth and skeletal maturation. A higher percentage of COPs is found in osteoporotic disease, which could constitute a predictive marker thereof. We also show how treatment with TPTD or DmAb mobilizes circulating osteogenic precursors in the blood. Significant increases in % COPs were observed after 12 months of treatment with Dmb (21.9%) and TPTD (17%). These results can be related to an increase in osteogenesis and, consequently, a better and more efficient repair of bone tissue.

6.
J Neurol ; 269(9): 4997-5007, 2022 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-35595971

RESUMO

BACKGROUND: We aimed to determine school performance and psychiatric comorbidity in juvenile absence epilepsy (JAE), juvenile myoclonic epilepsy (JME), and generalized tonic-clonic seizures (GTCS) alone. METHODS: All children (< 18 years) fulfilled International League Against Epilepsy criteria after review of their medical records. Control groups were the pediatric background population or children with non-neurological chronic disease. Outcomes were on school performance and psychiatric comorbidity. We compared mean grade point averages using linear regression and estimated hazard ratios using Cox regression in the remaining analyses. We adjusted for the child's sex, age, and year of birth; and parental highest education, receipt of cash benefits or early retirement. RESULTS: We included 92 JAE, 190 JME, 27 GTCS alone, 15,084 non-neurological chronic disease controls, and population controls. JAE had two times increased hazard for special needs education compared with age-matched population controls (hazard ratio 2.2, 95% CI = 1.1‒4.6, p = 0.03); this was not seen in JME. Compared with population controls, both JAE and JME had lower grade point average in secondary and high school (JME: 9th grade: - 0.5 points, 95% CI = -0.9 to -0.06, p = 0.03; high school: - 0.6 points, 95% CI = -1.3 to -0.1, p = 0.04), and 8% fewer JME and 15% fewer JAE attended high school. Both JME and JAE had higher hazard for redeeming sleep medication compared with non-neurological chronic disease; additionally, JAE had increased hazard for ADHD medicine redemptions. CONCLUSIONS: Both JAE and JME had marginally poorer school performance; performance seemed worse in JAE than in JME. Both JAE and JME had increased use of sleep medication.


Assuntos
Epilepsia Tipo Ausência , Epilepsia Mioclônica Juvenil , Criança , Estudos de Coortes , Comorbidade , Dinamarca/epidemiologia , Eletroencefalografia , Epilepsia Tipo Ausência/tratamento farmacológico , Epilepsia Tipo Ausência/epidemiologia , Humanos , Epilepsia Mioclônica Juvenil/epidemiologia , Convulsões/epidemiologia
7.
Clin Epidemiol ; 14: 501-509, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35469145

RESUMO

Objective: To identify pediatric idiopathic generalized epilepsy (IGE) during 1994-2019 using ICD-10 codes in the Danish National Patient Register and anti-seizure prescriptions in the Danish Prescription Database. Study Design and Setting: We reviewed the medical records in children with ICD-10 codes for IGE before 18 years of age, and pediatric neurologists confirmed that the International League Against Epilepsy criteria were met. We estimated positive predictive values (PPV) and sensitivity for ICD-10 alone, including combinations of codes, anti-seizure prescription, and age at first code registration using medical record-validated diagnoses as gold standard. Results: We validated the medical record in 969 children with an ICD-10 code of IGE, and 431 children had IGE (115 childhood absence epilepsy, 97 juvenile absence epilepsy, 192 juvenile myoclonic epilepsy, 27 generalized tonic-clonic seizures alone). By combining ICD-10 codes with antiseizure prescription and age at epilepsy code registration, we found a PPV for childhood absence epilepsy at 44% (95% confidence interval [CI]=34%‒54%) and for juvenile absence epilepsy at 44% (95% CI=36%-52%). However, ethosuximide prescription, age at ethosuximide code registration before age 8 years and a combination of ICD-10 codes yielded a PPV of 59% (95% CI=42%‒75%) for childhood absence epilepsy but the sensitivity was only 17% (20/115 children identified). For juvenile myoclonic epilepsy the highest PPV was 68% (95% CI=62%‒74%) using the code G40.3F plus antiseizure prescription and age at epilepsy code registration after age 8 years, with sensitivity of 85% (164/192 children identified). For generalized tonic-clonic seizures alone the highest PPV was 31% (95% CI=15%‒51%) using G40.3G during 2006-2019 plus antiseizure prescription and age at code registration after age 5 years. Conclusion: The Danish National Patient Register and the Danish Prescription Database are not suitable for identifying children with IGE subtypes, except for juvenile myoclonic epilepsy which can be identified with caution.

8.
Contracept X ; 3: 100070, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34746745

RESUMO

OBJECTIVES: To identify the lowest dose of Depo-Provera that, when administered off-label subcutaneously, suppressed ovulation and had a pharmacokinetic profile consistent with a 4-month contraceptive effect. STUDY DESIGN: We conducted a randomized, multicenter, parallel-group study to evaluate the pharmacokinetics (PK) and pharmacodynamics (PD) of medroxyprogesterone acetate (MPA) after subcutaneous injection of three different doses of Depo-Provera. We randomized sixty women between 18 and 40 years of age at low risk of pregnancy with confirmed ovulation and body mass index of 18 to 35 kg/m2 to receive a single injection of 45, 75 or 105 mg of Depo-Provera, or a single injection of Depo-subQ provera 104 as a reference drug (15 women per group) and followed them for 7.5 months. We evaluated suppression of ovulation as the primary outcome, and MPA concentrations, pharmacokinetic parameters, safety, and local tolerability as secondary outcomes. RESULTS: Five women ovulated within four months of treatment initiation (three in the 45 mg group and two in the 75 mg group). MPA levels associated with ovulation were in general low, largely ≤ 0.2 ng/mL (the presumed contraceptive threshold). No women in either the 105 mg group or the Depo-subQ provera 104 group ovulated within four months. The PK parameters including Cmax, C119, and AUC0-119 for these 2 groups were similar but not equivalent. CONCLUSION: A dose of 105 mg of Depo-Provera injected subcutaneously was the lowest tested dose that consistently suppressed ovulation and maintained serum MPA levels consistent with contraceptive effect for at least 4 months. The PK and PD results for the 105 mg dose were similar to Depo-subQ provera 104 over this period.

9.
Diagnostics (Basel) ; 11(3)2021 Mar 23.
Artigo em Inglês | MEDLINE | ID: mdl-33806850

RESUMO

Type 2 diabetes mellitus (T2DM) is one of the most common chronic diseases worldwide and it is associated with an increased risk of osteoporosis and fragility fractures. Our aim is to analyze the effect of T2DM on bone quality. This is a case-control study. The studied population consisted of 140 patients: 54 subjects with hip fracture (OP) without T2DM, 36 patients with hip fracture and T2DM (OP-T2DM), 28 patients with osteoarthritis (OA) without T2DM, and 22 patients with OA and T2DM (OA-T2DM). Bone markers, bone mineral density, FRAX score, microstructural, and bone material strength from femoral heads were assessed. The group with hip fracture presented lower BMD values than OA (p < 0.05). The OP, OP-T2DM, and OA-T2DM groups showed a decrease in bone volume fraction (BV/TV), in trabecular number (Tb.N), and in trabecular thickness (Tb.Th), while an increase was presented in the structural model index (SMI) and trabecular bone pattern factor (Tb.Pf), The groups OP, OP-T2DM, and OA-T2DM also presented lower values than those in group OA regarding the biomechanical parameters in the form of Young's modulus or elastic modulus, toughness, ultimate stress, ultimate load, extrinsic stiffness, and work to failure (p < 0.05). Our results show the negative effect of type 2 diabetes mellitus on trabecular bone structure and mechanical properties.

10.
Rev. biol. trop ; 68(1)mar. 2020.
Artigo em Inglês | LILACS-Express | LILACS | ID: biblio-1507646

RESUMO

Introduction: The gastropod Bostryx torallyi shows high variability in shell shape and coloration. Subspecies of this organism have been described based on shell characters but, since they were slightly different, they were synonymized afterwards. Until now, shell variability has been analyzed only descriptively and its anatomy is still unknown. Objective: In this study, I provide anatomical information of B. torallyi and apply a geometric morphometric analysis to evaluate the shell shape variation among specimens. Methods: To accomplish this, type material and numerous lots were examined and dissected out. Additionally, relative warp analysis, based on 9 landmarks in ventral view of the shell, was performed using 80 specimens of 9 localities from Bolivia and Argentina. Results: According to our results, geometric morphometrics is a suitable method to evaluate differences in shell shape among localities; for instance, distinctions in the shell were noticeable between gastropods of low and high altitudes. On the other hand, it was established that the coloration of this species is independent of large-scale factors since the examined specimens came from environments with similar conditions. Furthermore, the sculpture of the protoconch and anatomy of B. torallyi coincided with the other Argentinian species of the genus. Conclusions: Therefore, I concluded that a geometric morphometric analysis of shell shape is a good complement to traditional qualitative description of the characteristics of the shell in this species.


Introducción: El gasterópodo Bostryx torallyi exhibe una gran variabilidad en la forma y coloración de su concha. Subespecies de este organismo han sido descritas con base en los caracteres de la concha; pero, dadas las sutiles diferencias, fueron luego sinonimizadas. Hasta el momento, la variabilidad de la concha ha sido analizada solo descriptivamente y su anatomía es aún desconocida. Objetivo: En este estudio, los objetivos fueron:proveer información anatómica de B. torallyi y usar un análisis de morfometría geométrica para evaluar la variación de la forma de la concha entre especímenes. Métodos: Para ello, se examinó y disectó material tipo y numerosos lotes. Adicionalmente, se realizaron análisis del "relative warp", basados en nueve "landmarks" en vista ventral de la concha, empleando 80 especímenes de nueve localidades de Bolivia y Argentina. Resultados: De acuerdo con los resultados, la morfometría geométrica resultó útil para demostrar diferencias en forma de la concha entre localidades; por ejemplo, se detectarondiferencias evidentes entre localidades de alta y baja altitud. Se determinó que la variación en la coloración de esta especie es independiente de factores a gran escala, dado que los especímenes examinados proceden de ambientes con condiciones similares. Por otro lado, la escultura de la protoconcha y la anatomía de B. torallyi resultaron coincidentes con la de otras especies de este género recolectadas en Argentina. Conclusiones: Se concluyó que el análisis de morfometría geométrica de la forma de la concha fue un buen complemento a la descripción cualitativa tradicional de caracteres de concha.

11.
PeerJ ; 6: e5986, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30564514

RESUMO

BACKGROUND: Land gastropods of the Dry Chaco merit special attention because they comprise a highly diverse but barely studied group. Clessinia Doering, 1875 are typical inhabitants of this ecoregion. The inclusion of their distribution areas into Spixia range, their shell shape similarities, and a former molecular study raised doubts on the monophyly of this genus. The present study review the species of Clessinia, under a morphological, geometric morphometrics, and molecular combined approach. METHODS: Adults were collected, photographed, measured, and dissected for anatomical studies. Shell ultrastructure was studied with scanning electron microscope. Geometric morphometric analyses on shells were performed testing if they gave complementary information to anatomy. Two mitochondrial genes, and a nuclear region were studied. Phylogenetic reconstructions to explore the relationships of DNA sequences here obtained to those of Clessinia and Spixia species from GenBank were performed. RESULTS: Species description on shell, periostracal ornamentation and anatomy is provided. We raised former Clessinia cordovana striata to species rank, naming it as Clessinia tulumbensis sp. nov. The periostracum, consisting of hairs and lamellae, has taxonomic importance for species identification. Shell morphometric analyses, inner sculpture of penis and proportion of the epiphallus and penis, were useful tools to species identification. Nuclear markers do not exhibit enough genetic variation to determine species relationships. Based on the mitochondrial markers, genetic distances among Clessinia species were greater than 10%, and while C. cordovana, C. nattkemperi, and C. pagoda were recognized as distinct evolutionary genetic species, the distinction between C. stelzneri and C. tulumbensis sp. nov. was not evident. Clessinia and Spixia were paraphyletic in the molecular phylogenetic analyses. Species of Clessinia here treated have narrow distributional areas and are endemic to the Chaco Serrano subecoregion, restricted to small patches within the Dry Chaco. Clessinia and Spixia are synonymous, and the valid name of the taxon should be Clessinia Doering, 1875 which has priority over Spixia Pilsbry & Vanatta, 1894. DISCUSSION: Our results support the composition of C. cordovana complex by three species, C. cordovana, C. stelzneri, and C. tulumbensis sp. nov. The low genetic divergence between C. stelzneri and C. tulumbensis sp. nov. suggests that they have evolved relatively recently. The former Spixia and Clessinia are externally distinguished because Clessinia has a detached aperture from the body whorl forming a cornet, periostracal microsculpture extended over dorsal portion of the peristome, five inner teeth on the shell aperture instead of three-four found in Spixia. Morphological similarities exists between both genera in shell shape, type of periostracum microsculpture, reproductive anatomy, besides the overlap in geographic ranges.

12.
Ugeskr Laeger ; 179(48)2017 Nov 27.
Artigo em Dinamarquês | MEDLINE | ID: mdl-29208197

RESUMO

Recent literature indicates, that rolandic epilepsy/epilepsy of childhood with centrotemporal spikes may not be as benign as previously assumed. This study investigates the existing evidence, which describes the treatment effects on seizure frequency as well as improvement of cognition in children with rolandic epilepsy. We conclude, that treatment with anti-epileptic drugs could be justified, if treatment reduces seizures, prevents the evolution to atypical forms, or diminishes the negative cognitive consequences associated with the disease. Levetiracetam and sulthiame are the recommended treatments according to the existing evidence, which is still insufficient. A larger randomized controlled trial is warranted.


Assuntos
Anticonvulsivantes/uso terapêutico , Epilepsia Rolândica/tratamento farmacológico , Criança , Transtornos Cognitivos/etiologia , Eletroencefalografia , Epilepsia Rolândica/complicações , Epilepsia Rolândica/diagnóstico , Humanos , Levetiracetam/uso terapêutico , Tiazinas/uso terapêutico
13.
Ecol Evol ; 7(14): 5502-5513, 2017 07.
Artigo em Inglês | MEDLINE | ID: mdl-28770086

RESUMO

Freshwater ecosystems are the most threatened ecosystems worldwide. Argentinian-protected areas have been established mainly to protect vertebrates and plants in terrestrial ecosystems. In order to create a comprehensive biodiverse conservation plan, it is crucial to integrate both aquatic and terrestrial systems and to include macroinvertebrates. Here, we address this topic by proposing priority areas of conservation including invertebrates, aquatic ecosystems, and their connectivity and land uses. LOCATION: Northwest of Argentina. We modeled the ecological niches of different taxa of macroinvertebrates such as Coleoptera, Ephemeroptera, Hemiptera, Megaloptera, Lepidoptera, Odonata, Plecoptera, Trichoptera, Acari, and Mollusca. Based on these models, we analyzed the contribution of currently established protected areas in the conservation of the aquatic biodiversity and we propose a spatial prioritization taking into account possible conflict regarding different land uses. Our analysis units were the real watersheds, to which were added longitudinal connectivity up and down the rivers. A total of 132 species were modeled in the priority area analyses. The analysis 1 showed that only an insignificant percentage of the macroinvertebrates distribution is within the protected areas in the North West of Argentina. The analyses 2 and 3 recovered similar values of protection for the macroinvertebrate species. The upper part of Bermejo, Salí-Dulce, San Francisco, and the Upper part of Juramento basins were identified as priority areas of conservation. The aquatic ecosystems need special protection and 10% or even as much as 17% of land conservation is insufficient for species of macroinvertebrates. In turn the protected areas need to combine the aquatic and terrestrial systems and need to include macroinvertebrates as a key group to sustain the biodiversity. In many cases, the land uses are in conflict with the conservation of biodiversity; however, it is possible to apply the connectivity of the watersheds and create multiple-use modules.

14.
Recurso educacional aberto em Português | CVSP - Brasil | ID: una-7559

RESUMO

Esta obra, que faz parte da coleção "Cadernos de Saúde da Família", elaborada pela UNA-SUS/UFMA, é composta por dois capítulos, que são: "Políticas, programas e rede de atenção à saúde do idoso", que analisa o processo de envelhecimento no Brasil e a instituição de programas e políticas que visam garantir o direito à saúde para população idosa; e "Principais agravos crônicos de saúde da pessoa idosa", que descreve o diagnóstico e o manejo clínico dos principais agravos na saúde do idoso.


Assuntos
Saúde do Idoso , Programas Nacionais de Saúde , Estratégias de Saúde Nacionais , Humanização da Assistência , Serviços de Saúde para Idosos
15.
JAMA ; 316(22): 2411-2421, 2016 12 13.
Artigo em Inglês | MEDLINE | ID: mdl-27893068

RESUMO

Importance: Human papillomavirus (HPV) infections cause anogenital cancers and warts. The 9-valent HPV vaccine provides protection against 7 high-risk types of HPV responsible for 90% of cervical cancers and 2 other HPV types accounting for 90% of genital warts. Objective: To determine whether HPV type-specific antibody responses would be noninferior among girls and boys aged 9 to 14 years after receiving 2 doses of the 9-valent HPV vaccine compared with adolescent girls and young women aged 16 to 26 years receiving 3 doses. Design, Setting, and Participants: Open-label, noninferiority, immunogenicity trial conducted at 52 ambulatory care sites in 15 countries. The study was initiated on December 16, 2013, with the last participant visit for this report on June 19, 2015. Five cohorts were enrolled: (1) girls aged 9 to 14 years to receive 2 doses 6 months apart (n = 301); (2) boys aged 9 to 14 years to receive 2 doses 6 months apart (n = 301); (3) girls and boys aged 9 to 14 years to receive 2 doses 12 months apart (n = 301); (4) girls aged 9 to 14 years to receive 3 doses over 6 months (n = 301); and (5) a control group of adolescent girls and young women aged 16 to 26 years to receive 3 doses over 6 months (n = 314). Interventions: Two doses of the 9-valent HPV vaccine administered 6 or 12 months apart or 3 doses administered over 6 months. Main Outcomes and Measures: The primary end point was prespecified as the antibody response against each HPV type assessed 1 month after the last dose using a competitive immunoassay. Each of the three 2-dose regimens was compared with the standard 3-dose schedule in adolescent girls and young women using a noninferiority margin of 0.67 for the ratio of the antibody geometric mean titers. Results: Of the 1518 participants (753 girls [mean age, 11.4 years]; 451 boys [mean age, 11.5 years]; and 314 adolescent girls and young women [mean age, 21.0 years]), 1474 completed the study and data from 1377 were analyzed. At 4 weeks after the last dose, HPV antibody responses in girls and boys given 2 doses were noninferior to HPV antibody responses in adolescent girls and young women given 3 doses (P < .001 for each HPV type). Compared with adolescent girls and young women who received 3 doses over 6 months, the 1-sided 97.5% CIs for the ratio of HPV antibody geometric mean titers at 1 month after the last dose across the 9 HPV subtypes ranged from 1.36 to ∞ to 2.50 to ∞ for girls who received 2 doses 6 months apart; from 1.37 to ∞ to 2.55 to ∞ for boys who received 2 doses 6 months apart; and from 1.61 to ∞ to 5.36 to ∞ for girls and boys who received 2 doses 12 months apart. Conclusions and Relevance: Among girls and boys aged 9 to 14 years receiving 2-dose regimens of a 9-valent HPV vaccine separated by 6 or 12 months, immunogenicity 4 weeks after the last dose was noninferior to a 3-dose regimen in a cohort of adolescent girls and young women. Further research is needed to assess persistence of antibody responses and effects on clinical outcomes. Trial Registration: clinicaltrials.gov Identifier: NCT01984697.


Assuntos
Esquemas de Imunização , Infecções por Papillomavirus/prevenção & controle , Vacinas contra Papillomavirus/administração & dosagem , Vacinas contra Papillomavirus/imunologia , Adolescente , Adulto , Fatores Etários , Especificidade de Anticorpos , Criança , Estudos de Coortes , Fenômenos Fisiológicos da Nutrição do Idoso , Feminino , Genótipo , Humanos , Imunogenicidade da Vacina , Masculino , Papillomaviridae/genética , Papillomaviridae/imunologia , Vacinas contra Papillomavirus/efeitos adversos , Fatores Sexuais , Fatores de Tempo , Adulto Jovem
16.
Ugeskr Laeger ; 177(50): V07150587, 2015 Dec 07.
Artigo em Dinamarquês | MEDLINE | ID: mdl-26651911

RESUMO

Demyelinating diseases in children is a broad group of illnesses, which affect the central nervous system. Demyelinating diseases can be monophasic or chronic and comprise acute disseminated encephalomyelitis, optic neuritis, transverse myelitis, multiple sclerosis and neuromyelitis optica. Demyelinating diseases are rare, but it is important for the physician to recognize these diseases, as well as to understand the differential diagnoses. This review summarizes the current knowledge of demyelinating disorders in children, focusing on an approach to diagnosis and management.


Assuntos
Doenças Desmielinizantes , Criança , Pré-Escolar , Doenças Desmielinizantes/líquido cefalorraquidiano , Doenças Desmielinizantes/diagnóstico , Doenças Desmielinizantes/tratamento farmacológico , Diagnóstico Diferencial , Encefalomielite Aguda Disseminada/líquido cefalorraquidiano , Encefalomielite Aguda Disseminada/diagnóstico , Encefalomielite Aguda Disseminada/tratamento farmacológico , Humanos , Imageamento por Ressonância Magnética , Metilprednisolona/administração & dosagem , Metilprednisolona/uso terapêutico , Esclerose Múltipla/líquido cefalorraquidiano , Esclerose Múltipla/diagnóstico , Esclerose Múltipla/tratamento farmacológico , Mielite Transversa/líquido cefalorraquidiano , Mielite Transversa/diagnóstico , Mielite Transversa/tratamento farmacológico , Neuromielite Óptica/líquido cefalorraquidiano , Neuromielite Óptica/diagnóstico , Neuromielite Óptica/tratamento farmacológico , Fármacos Neuroprotetores/administração & dosagem , Fármacos Neuroprotetores/uso terapêutico , Neurite Óptica/líquido cefalorraquidiano , Neurite Óptica/diagnóstico , Neurite Óptica/tratamento farmacológico
17.
Ugeskr Laeger ; 177(29)2015 Jul 13.
Artigo em Dinamarquês | MEDLINE | ID: mdl-26239959

RESUMO

Acute disseminated encephalomyelitis (ADEM) is an immune-mediated inflammatory paediatric disorder of the central nervous system (CNS). ADEM primarily affects the white matter of the brain and spinal cord. The aetiology of ADEM is unknown, but the illness is often precipitated by an infection, less often by vaccination. ADEM is characterized by acute polyfocal CNS deficit, including encephalopathy. This can be seen on MRI as simultaneously occurring multifocal lesions. Empirical treatment with steroids or immunoglobulins is often used. The prognosis of ADEM is usually favourable. This article describes two Danish cases both demonstrating trait characteristics of ADEM as well as the importance of an MRI considering an ADEM diagnosis early in the course of the illness.


Assuntos
Encefalomielite Aguda Disseminada , Doença Aguda , Criança , Pré-Escolar , Diagnóstico Diferencial , Encefalomielite Aguda Disseminada/diagnóstico , Encefalomielite Aguda Disseminada/diagnóstico por imagem , Encefalomielite Aguda Disseminada/tratamento farmacológico , Feminino , Humanos , Imageamento por Ressonância Magnética , Masculino , Esteroides/administração & dosagem , Esteroides/uso terapêutico
18.
Contraception ; 90(6): 565-74, 2014 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-25193534

RESUMO

OBJECTIVE: To determine whether a 3-month contraceptive vaginal ring (CVR) delivering ulipristal acetate (UPA) can inhibit ovulation in 90% of cycles. STUDY DESIGN: This was a randomized dose-finding parallel group clinical trial. Fifty-five healthy women with normal ovulation at baseline were randomized to receive a low-dose (1500 µg/day) or a high-dose (2500 µg/day) UPA-CVR for two consecutive 12-week treatment periods, followed by a recovery cycle. A subgroup of women received levonorgestrel (LNG) 1.5 mg orally twice (at the end of both 12-week ring periods) or once (at the end of the 24-week treatment). The primary outcome was ovulation suppression assessed by transvaginal ultrasound and hormone levels. Secondary outcomes included endometrial safety and bleeding patterns. RESULTS: All subjects showed normal ovulation at baseline and recovery. Ovulation suppression was seen in 81.8% (95% CI: 73.3%, 88.5%) and 86.1% (95% CI: 78.1%, 92%) of treatment cycles with low and high-dose, respectively. Benign progesterone receptor modulator associated endometrial changes (PAEC) were seen during treatment; 78.8% at week 24, but resolved at recovery cycle. A few cases of heavy bleeding occurred near the end of the 24-week treatment, but a single dose of LNG every 12 weeks reduced the increase in endometrial thickness during the second treatment period and prevented excessive bleeding. CONCLUSION: The 3-month UPA-CVR may become an effective long-acting, user-controlled estrogen-free contraceptive. The greatest suppression of ovulation was seen with the 2500-µg/day ring. IMPLICATIONS: The 3-month CVR delivering UPA 2500 µg/day can become an effective user-controlled estrogen-free contraceptive method. Benign PAEC during treatment returns to normal after discontinuation. The prevention of occasional excessive withdrawal bleeding, either by a progestin or by using higher UPA levels to increase follicle suppression may permit prolonged treatment.


Assuntos
Anticoncepção/métodos , Anticoncepcionais Femininos/administração & dosagem , Dispositivos Anticoncepcionais Femininos , Norpregnadienos/administração & dosagem , Adulto , Anticoncepcionais Femininos/efeitos adversos , Anticoncepcionais Femininos/sangue , Anticoncepcionais Femininos/farmacologia , Endométrio/efeitos dos fármacos , Feminino , Humanos , Norpregnadienos/efeitos adversos , Norpregnadienos/sangue , Norpregnadienos/farmacologia , Folículo Ovariano/efeitos dos fármacos , Testes de Função Ovariana , Ovário/efeitos dos fármacos , Ovulação/efeitos dos fármacos , Inibição da Ovulação/efeitos dos fármacos , Receptores de Progesterona/administração & dosagem , Receptores de Progesterona/efeitos dos fármacos , Hemorragia Uterina/tratamento farmacológico , Vagina/efeitos dos fármacos , Adulto Jovem
19.
Contraception ; 85(5): 480-8, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22176795

RESUMO

BACKGROUND: Progesterone receptor modulators (PRMs) delivered by contraceptive vaginal rings provide an opportunity for development of an estrogen-free contraceptive that does not require daily oral intake of steroids. The objective of this proof-of-concept study was to determine whether continuous delivery of 600-800 mcg of ulipristal acetate (UPA) from a contraceptive vaginal ring could achieve 80% to 90% inhibition of ovulation. STUDY DESIGN: This was a prospective, controlled, open-labeled, multicenter international trial to examine the effectiveness and safety of this prototype vaginal ring. Thirty-nine healthy women, 21-40 years old and not at risk of pregnancy, were enrolled at three clinic sites. Volunteers participated in a control cycle, a 12-week treatment period and a post-treatment cycle. Pharmacodynamic effects on follicular function and inhibition of ovulation, effects on endometrium, bleeding patterns and serum UPA levels were evaluated. RESULTS: Mean UPA levels during treatment were nearly constant, approximately 5.1 ng/mL throughout the study. Ovulation was documented in 32% of 111 "4-week treatment cycles." A correlation was observed between serum UPA and degree of inhibition of ovarian activity. There was no evidence of hyperplasia of endometrium, but PRM-associated endometrial changes were frequently observed (41%). CONCLUSION: In this study, the minimum effective contraceptive dose was not established. Further studies are required testing higher doses of UPA to attain ovulation suppression in a higher percentage of subjects.


Assuntos
Anticoncepcionais Femininos/farmacologia , Dispositivos Anticoncepcionais Femininos , Endométrio/efeitos dos fármacos , Menstruação/efeitos dos fármacos , Norpregnadienos/farmacologia , Inibição da Ovulação/efeitos dos fármacos , Receptores de Progesterona/antagonistas & inibidores , Adulto , Biomarcadores/metabolismo , Proliferação de Células/efeitos dos fármacos , Anticoncepcionais Femininos/administração & dosagem , Anticoncepcionais Femininos/efeitos adversos , Anticoncepcionais Femininos/farmacocinética , Dispositivos Anticoncepcionais Femininos/efeitos adversos , Preparações de Ação Retardada/administração & dosagem , Preparações de Ação Retardada/efeitos adversos , Preparações de Ação Retardada/farmacocinética , Preparações de Ação Retardada/farmacologia , Endométrio/citologia , Endométrio/metabolismo , Feminino , Antagonistas de Hormônios/administração & dosagem , Antagonistas de Hormônios/efeitos adversos , Antagonistas de Hormônios/farmacocinética , Antagonistas de Hormônios/farmacologia , Humanos , Imuno-Histoquímica , Menstruação/sangue , Menstruação/metabolismo , Norpregnadienos/administração & dosagem , Norpregnadienos/efeitos adversos , Norpregnadienos/farmacocinética , Folículo Ovariano/efeitos dos fármacos , Adulto Jovem
20.
Rev. biol. trop ; 58(3): 1009-1029, Sept. 2010. graf, tab
Artigo em Espanhol | LILACS | ID: lil-637978

RESUMO

Biodiversity of land gastropods (Mollusca) in Sierra de San Javier Park, Tucumán, Argentina. Studies related to land mollusk diversity in tropical and subtropical forests are scarce. To assess this, a study on land snail diversity of subtropical cloudforest (Yungas) and dry forest (Chaco) areas of Sierra de San Javier Park, Tucumán, Argentina, was carried out. Taxonomic identifications were performed to species level and built a species per stations data matrix to analyze diversity patterns on qualitative and quantitative samples processed from 10x10m quadrates in altitudinal transects. Non parametric analysis (ICE, ACE, Chao 1 and Chao 2) were used to estimate the true diversity of the area, as well as the degree of undersampling and spatial aggregation of the data. Diversity was also calculated using Shannon, Simpson, Whittaker and Jaccard indices. The richness of the San Javier Park was estimated to be 32 species distributed into 13 families and 21 genera. From the total number of species collected, a single one belongs to Caenogastropoda, while the rest of the species are classified into Pulmonata Stylommatophora and Systellommatophora. The most representative family was the micromollusc Charopidae, while the most relatively abundant species was another micromollusc snail, Adelopoma tucma. Richness and diversity were slightly more elevated in dry forest areas of the Chacoan Ecoregion than in cloud forest areas of Yungas. Non parametric estimators showed that the inventory was complete. Diversity values obtained were high in comparison to previously studied areas of Northwestern Argentina. The total number of specimen collected (22 169 specimens), was higher than other published studies. Rev. Biol. Trop. 58 (3): 1009- 1029. Epub 2010 September 01.


Se realizó un inventario y se analizaron parámetros de diversidad de la malacofauna terrestre del Parque Biológico Sierra de San Javier. Se llevaron a cabo muestreos cualitativos y cuantitativos en parcelas de 10x10m tomadas en transectas altitudinales, para un total de 22 169 especímenes recolectados. Las identificaciones taxonómicas se llevaron a cabo a nivel de especie. Se construyó una matriz de especies por parcela para analizar patrones de diversidad y se utilizaron estimadores no paramétricos (ICE, ACE, Chao 1 y Chao 2) para calcular la diversidad del Parque, el grado de completitud del muestreo y la agregación espacial de los datos. Se calcularon los índices de Shannon, Simpson, Whittaker y Jaccard. La riqueza del Parque fue estimada en 32 especies distribuidas en 21 géneros y 13 familias. Solo una especie pertenece a Caenogastropoda, el resto son Pulmonados Stylommatophora y Systellommatophora. La familia más representada fue Charopidae mientras que la especie con mayor abundancia relativa fue Adelopoma tucma. La riqueza y diversidad fue levemente mayor en chaco seco que en bosque húmedo de Yungas. Los valores de diversidad obtenidos fueron elevados en comparación con estudios previos realizados en el noroeste Argentino.


Assuntos
Animais , Biodiversidade , Moluscos/classificação , Argentina , Densidade Demográfica , Árvores
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...